Adeno-associated virus vector as a platform for gene therapy delivery

Adeno-associated virus vector as a platform for gene therapy delivery

Adeno-associated virus vector as a platform for gene therapy delivery, Published online: 01 February 2019; doi:10.1038/s41573-019-0012-9

Adeno-associated virus (AAV) vectors represent the leading platform for therapeutic gene delivery, with two recombinant AAV gene therapy products having gained regulatory approval in Europe or the United States. Here, Gao and colleagues discuss the fundamentals of AAV and vectorology, focusing on current therapeutic strategies, clinical progress and ongoing challenges.

Articles You May Like

Bugs Vs. Superbugs: Insects Offer Promise In Fight Against Antibiotic Resistance
MultiDomainBenchmark: a multi-domain query and subject database suite
Identifying the mechanism for superdiffusivity in mouse fibroblast motility
A hierarchical sparse coding model predicts acoustic feature encoding in both auditory midbrain and cortex
FunMappOne: a tool to hierarchically organize and visually navigate functional gene annotations in multiple experiments

Leave a Reply

Your email address will not be published. Required fields are marked *